Methods for performing antisense oligonucleotide-mediated exon skipping in the retina of a subject in need thereof
US11667913B2 · kind B2 · utility
0Cited by
0References
9Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 8, 2014 |
| Grant date | Jun 6, 2023 |
| Priority date | — |
| Expiry date | Jul 8, 2034 |
Classification
- Technology area (CPC H)Electricity
- CPC primaryH04W72/52
- WIPO fieldDigital communication
- WIPO sectorElectrical engineering
Abstract
The present invention relates to methods for performing antisense oligonucleotide-mediated exon skipping in the retina of a subject in need thereof. In particular, the present invention relates to a method for performing antisense oligonucleotide-mediated exon skipping in a retina cell of a subject comprising the step of injecting into the vitreous of the subject an amount of the antisense oligonucleotide.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.